Equities

Niox Group PLC

NIOX:LSE

Niox Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)66.00
  • Today's Change0.00 / 0.00%
  • Shares traded870.41k
  • 1 Year change8.55%
  • Beta-0.0461
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Profile data is unavailable for this security.

About the company

NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.

  • Revenue in GBP (TTM)46.00m
  • Net income in GBP4.90m
  • Incorporated2006
  • Employees84.00
  • Location
    Niox Group PLCMagdalen Centre, 1 Robert Robinson AveOXFORD OX4 4GAUnited KingdomGBR
  • Phone+44 18 6540 5560Fax+44 18 6578 4576
  • Websitehttps://investors.niox.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Natac Natural Ingredients SA28.31m-5.09m267.99m184.00267.99m184.00
Akebia Therapeutics Inc165.33m-11.68m270.95m181.00270.95m181.00
Enseval Putera Megatrading Tbk PT1.40bn33.02m271.34m5.08k271.34m5.08k
Niox Group PLC46.00m4.90m275.84m84.00275.84m84.00
Aarti Drugs Ltd204.47m16.43m277.25m1.28k277.25m1.28k
Orchid Pharma Ltd66.59m4.24m279.87m737.00279.87m737.00
Data as of Feb 06 2026. Currency figures normalised to Niox Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

50.07%Per cent of shares held by top holders
HolderShares% Held
Harwood Capital LLPas of 21 May 202570.32m16.83%
Rathbones Investment Management Ltd.as of 07 Oct 202541.75m9.99%
Raymond James Wealth Management Ltd. (Investment Management)as of 25 Nov 202520.87m4.99%
Woodford Investment Management Ltd.as of 01 Nov 202515.26m3.65%
Artemis Investment Management LLPas of 20 Jan 202613.43m3.22%
Danske Bank A/S (Investment Management)as of 30 Sep 202512.48m2.99%
Morgan Stanley Smith Barney LLC (Investment Management)as of 01 Nov 20259.71m2.32%
Invesco Asset Management Ltd.as of 01 Apr 20259.04m2.16%
Brooks Macdonald Asset Management Ltd.as of 09 Apr 20258.84m2.12%
JPMorgan Asset Management (UK) Ltd.as of 11 Apr 20257.53m1.80%
More ▼
Data from 31 Jul 2025 - 29 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.